copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Bio-Rad Careers (Global homepage) If you don't know Bio-Rad, then we invite you to discover a company that has enjoyed 70 years of We are a global team of innovators, builders, and leaders who create a broad array of clinical diagnostics and life science research products for thousands of customers across the globe
Quality Controls, Data Management Services – QCNet | Bio-Rad QC solutions designed to improve workflow and efficiency, minimize risk and costly errors, maintain compliance and accreditation, and produce consistent results while running a cutting-edge lab—that’s the Bio-Rad promise
Bio-Rad Laboratories, Inc. - Investor Relations Download Bio-Rad annual reports, SEC filings, and quarterly results Get investor kits, corporate information, and answers to company and stock FAQs
首页 | Bio-Rad Bio-Rad's Life Science Research division offers products, services, and information for electrophoresis, imaging, PCR amplification, sample prep, and more
Bio-Rad Products With Bio-Rad’s range of systems and products spanning from infectious diseases and bacteriology to molecular diagnostics and newborn screening, you can get the answers you need with the clarity your patients deserve
Bio-Rad Laboratories - LinkedIn Bio-Rad Laboratories | 426,082 followers on LinkedIn We advance science and save lives, together | Bio-Rad provides the healthcare industry with innovative and useful products that help life
5 Analysts Have This To Say About Bio-Rad Laboratories Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish The following table provides a quick
Quality Controls – QCNet | Bio-Rad Bio-Rad offers independent quality controls for clinical diagnostics laboratories that help streamline workflows, reduce errors, maintain compliance, and facilitate accreditation
Bio-Rad Laboratories (NYSE:BIO. B) Hits New 52-Week Low - MarketBeat Bio-Rad Laboratories (NYSE:BIO B - Get Free Report) last released its earnings results on Thursday, May 1st The company reported $2 54 earnings per share (EPS) for the quarter Bio-Rad Laboratories had a negative net margin of 71 86% and a positive return on equity of 3 90% The business had revenue of $585 40 million for the quarter